News for Healthier Living

Carvedilol Associated with Lower Risk of Cirrhosis Complications Than Other Beta-Blockers

A retrospective cohort study of U.S. adults with cirrhosis found that treatment with the beta-blocker carvedilol was associated with meaningful lower rates of major decompensation events, such as fluid buildup, bleeding, or infection, within six months compared with those taking nadolol or propranolol.

July 6, 2026


July 10 2026

July 9 2026

July 8 2026

July 7 2026

July 6 2026

July 3 2026

July 2 2026

July 1 2026

June 30 2026

June 29 2026